Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Remain Cool and Solid: Top Summer Food sources for 2024 - 2Sexual violence part of 'everyday life' in parts of Sudan, charity says
- 3Archaeologists uncover details about the Hjortspring boat's origins
- 4Nearly 16,000 New York City nurses prepare to strike as contract talks stall
- 5Schools to start reopening after Nigeria mass abduction
- Dark matter obeys gravity after all — could that rule out a 5th fundamental force in the universe?
- Lift Your Style: Famous Hairdos for Ladies
- The Job of Attorneys: It is Important to Comprehend When Legitimate Help
- 5 High Limit Outer Hard Drives For Information Stockpiling
- The best ice packs for coolers of 2026, tested and reviewed
- The Craft of Do-It-Yourself Home Stylistic layout: Change Your Space
- First Houthi launch toward Israel since war began triggers alerts across the Negev
- Court clears Beersheba assault suspect of link to Haymanut Kasau disappearance, extends detention
- Vote In favor of Feasible Way You Prescribe to Shop for Garments
